《瑞銀窩輪》異動股部署 看好可留意裏康認購15251、中油認購15242
港股週三恆指急升500點後，週四靠穩，個別異動股包括阿裏健康（0241 ）、油股中石油（ 0857 ）。互聯網醫療股阿裏健康自疫情爆發以來，需求日漸增長；而根據上月公司公佈的業績，2021年第一季經調整利潤淨額近6.31億元人民幣，按年增長近2倍，爲近年來首次轉虧爲盈。隨着公司在醫藥服務方面力求進步，不少大行仍然維持對阿裏健康「買入」評級，投資者可密切留意阿裏健康的後市表現。如投資者看好阿裏健康，可留意裏康認購15251，行使價20.93港元，21年11月到期，有效槓桿約5.4倍。
至於中石油因國際油價上升而得以受惠，週四股價升2.6%，收報3.8港元，創近一年以來的新高。如投資者看好中石油，可留意認購15242，行使價4.05港元，21年12月到期，有效槓桿約4.8倍。
近日亦留意到資金流方面， 快手科技（ 1024 ）認購有顯着資金流入。快手自上週四開始失守200港元，股價一直停滯不前，最新跌4%，收市報192港元。如投資者希望趁低入市搏反彈，看好快手可留意認購22978，行使價259.08港元，21年10月到期，有效槓桿約6.5倍。
鍾情汽車股比亞迪（1211）、吉利（ 0175 ）的投資者，留意到兩隻正股升勢收窄甚至開始表現乏力，雖然比亞迪及吉利的認購仍然得到資金支持，但相比較早前，流入的資金的確有銳減的趨勢，投資者可密切留意汽車股後市表現作部署。如投資者看好比亞迪，可留意比迪認購22589，行使價259.08港元，21年9月到期，有效槓桿約5.5倍。如投資者看好吉利，可留意認購22215，行使價28.93港元，21年9月到期，有效槓桿約5.8倍。
更多窩輪牛熊資訊：瑞銀證網站： http://www.ubs.com/hkwarrants
窩證教學及市焦點況短片：
https://www.youtube.com/channel/UCKw86qy4eBAInmd52MND45Q?view_as=subscriber
卓素華
董事
瑞銀亞洲上市衍生產品銷售部主管
本產品並無抵押品。 如發行人無力償債或違約,投資者可能無法收回部份或全部應收款項。筆者爲UBS AG的代表(作爲證監會持牌人)，並未持有相關上市公司的任何財務權益。本資料由瑞銀刊發，其並不構成買賣建議、邀請、要約或遊說。結構性產品價格可急升或急跌，投資者可能會蒙受全盤損失。過往表現並不反映將來表現。牛熊證備強制贖回機制而可能被提早終止，屆時 (i) N類牛熊證投資者將不獲發任何金額;而(ii) R類牛熊證之剩餘價值可能爲零。投資前應瞭解有關風險，並諮詢專業顧問及查閱有關上市檔。UBS Securities Hong Kong Limited爲結構性產品之流通量提供者，亦可能是唯一報價者或市場參與者。(C) UBS 2021。版權所有。~
重要聲明:
以上資訊由第三方提供，AASTOCKS.com Limited對於任何包含於、經由、連結、下載或從任何與本網站有關服務所獲得之資訊、內容或廣告，不聲明或保證其內容之正確性或可靠性。對於您透過本網站上之廣告、資訊或要約而展示、購買或取得之任何產品、資訊資料，本公司亦不負品質保證之責任。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
